PHASE II STUDY OF AMRUBICIN IN PATIENTS WITH REFRACTORY OR RESISTANT RELAPSED SMALL-CELL LUNG CANCER: JAPAN CLINICAL ONCOLOGY GROUP STUDY (JCOG0901)

被引：0
|
作者：
Daga, H. [1 ]
Murakami, H.
Yamamoto, N. [6 ]
Shibata, T. [3 ]
Endo, M. [2 ]
Watanabe, H. [4 ]
Ichinose, Y. [5 ]
Yamamoto, N. [6 ]
Ohe, Y. [7 ]
Tamura, T. [6 ]
机构：
[1] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan
[2] Shizuoka Canc Ctr, Dept Radiol, Shizuoka, Japan
[3] Natl Canc Ctr, Regulatory Sci Sect, Multiinst Clin Trial Support Ctr, Tokyo, Japan
[4] Natl Canc Ctr, Dept Radiol, Tokyo, Japan
[5] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan
[6] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan
[7] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [41] A phase II study of doxifluridine in elderly patients with advanced gastric cancer: The Japan Clinical Oncology Group study (JCOG 9410)
    Ikeda, N
    Shimada, Y
    Ohtsu, A
    Boku, N
    Tsuji, Y
    Saito, H
    Koizumi, W
    Iwase, H
    Yoshida, S
    Fukuda, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (03) : 90 - 94
  • [42] Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702
    Inoue, Akira
    Sugawara, Shunichi
    Maemondo, Makoto
    Mori, Yoshiaki
    Oizumi, Satoshi
    Harada, Masao
    Taima, Kageaki
    Morikawa, Naoto
    Ishida, Takashi
    Kinoshita, Ichiro
    Watanabe, Hiroshi
    Suzuki, Toshiro
    Nakagawa, Taku
    Saito, Ryota
    Nukiwa, Toshihiro
    LUNG CANCER, 2015, 89 (01) : 61 - 65
  • [43] Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer
    Hirose, T
    Horichi, N
    Ohmori, T
    Ogura, K
    Hosaka, T
    Ando, K
    Ishida, H
    Noguchi, H
    Adachi, M
    LUNG CANCER, 2003, 40 (03) : 333 - 338
  • [44] Phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer (SCLC)
    Han, J.
    Lim, K. Y.
    Kim, H. Y.
    Han, J. H.
    Oh, S. H.
    Yun, T.
    Kim, H. T.
    Lee, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer
    Mori, K
    Kamiyama, Y
    Kondo, T
    Kano, Y
    Kodama, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (01) : 86 - 90
  • [46] Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer
    Kiyoshi Mori
    Yukari Kamiyama
    Tetsuro Kondo
    Yasuhiko Kano
    Tetsuro Kodama
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 86 - 90
  • [47] A Phase II Study of Amrubicin as a Third-Line or Fourth-Line Chemotherapy for Patients With Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901
    Harada, Toshiyuki
    Oizumi, Satoshi
    Ito, Kenichiro
    Takamura, Kei
    Kikuchi, Eiki
    Kuda, Tomoya
    Sugawara, Shunichi
    Suzuki, Aya
    Maemondo, Makoto
    Fujita, Yuka
    Kinoshita, Ichiro
    Inoue, Akira
    Hommura, Fumihiro
    Katsuura, Yutaka
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ONCOLOGIST, 2013, 18 (04): : 439 - 445
  • [48] A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer
    Inoue, Akira
    Yamazaki, Koichi
    Maemondo, Makoto
    Suzuki, Takuji
    Kimura, Yuichiro
    Kanbe, Mariko
    Isobe, Hiroshi
    Nishimura, Masaharu
    Saijo, Yasuo
    Nukiwa, Toshihiro
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (06) : 551 - 555
  • [49] Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective study
    Sone, Hideyuki
    Igawa, Satoshi
    Kasajima, Masashi
    Ishihara, Mikiko
    Hiyoshi, Yasuhiro
    Hosotani, Shinji
    Ohe, Shuntaro
    Ito, Hiroki
    Kaizuka, Nobuki
    Manaka, Hiroya
    Fukui, Tomoya
    Mitsufuji, Hisashi
    Kubota, Masaru
    Katagiri, Masato
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    THORACIC CANCER, 2018, 9 (10) : 1279 - 1284
  • [50] Phase II trial of gemcitabine/irinotecan in refractory or relapsed small-cell lung cancer
    Schuette, Wolfgang
    Nagel, Sylke
    Juergens, Stefan
    Bork, Ines
    Wollschlaeger, Bettina
    Schaedlich, Steffen
    Blankenburg, Thomas
    CLINICAL LUNG CANCER, 2005, 7 (02) : 133 - 137
12345